Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Therapeutic treatment with Y-320 (0
In turpentine oil-induced anemia in BALB/c mice
CCCCC1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCCN(CC)CC)C(I)=C1
InChi: InChI=1S/C21H11NO5S/c23-11-4-6-13-17(8-11)26-18-9-12(24)5-7-14(18)21(13)15-2-1-3-16(22-10-28)19(15)20(25)27-21/h1-9
Smiles: OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C21
Reversine Catalog No.:M10364-10 Therapeutic treatment with Y-320 (0Reversine is a small molecule developed by the group of Peter G. Schultz, used for stem cell dedifferentiation. Reversine is also a novel Aurora kinases inhibitor that inhibits colony formation of human acute myeloid leukemia cells. Reversine inhibits the phosphorylation of histone H3, a direct downstream target of Aurora kinases. Similarly to the Aurora kinase inhibitor VX 680, reversine inhibited colony formation of leukemic cells from patients with
US$ 42.00
US$ 116.00
US$ 233.50